Amgen’s Anemic Results
October 31, 2009 on 1:40 am | In Uncategorized | The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke.No Comments yet
Sorry, the comment form is closed at this time.
Powered by WordPress with Pool theme design by Borja Fernandez.